CytoMed Therapeutics GDTC Ratios (2021-2025)

NASDAQ GDTC
$0.86 -0.04 (-4.79%)
As of: Aug 21, 2026 · 9:54 AM EDT
Ratios Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Profitability
Net Margin (Quarter) 1,009.97%2,479.42%
Efficiency
Assets Average (Quarter) 8.84M11.54M10.04M9.24M7.96M7.26M
Invested Capital (Quarter) 0.02M0.22M0.01M0.33M0.01M0.32M0.32M
Leverage & Solvency
Interest Coverage Ratio (Quarter) 54.07
Times Interest Earned (Quarter) 54.07
Debt Ratio (Quarter) 0.150.150.000.040.040.040.040.05
Valuation
Enterprise Value (Quarter) -1.85M-2.51M-1.14M-10.44M-6.66M-9.00M-3.66M-4.62M-1.62M
Return Ratios
Return on Assets (Quarter) 0.00%-0.01%-0.01%